Alix Dubois
Nice, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Retraction Note: LAMP2 expression dictates azacytidine response and prognosis in MDS/AML.
Journal: Leukemia
Published: July 16, 2020
Acadesine Circumvents Azacitidine Resistance in Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Acadesine Circumvents Azacitidine Resistance in Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Journal: International journal of molecular sciences
Published: October 23, 2019
LAMP2 expression dictates azacytidine response and prognosis in MDS/AML.
Journal: Leukemia
Published: June 08, 2018
In Vitro and in Vivo Evaluation of Fully Substituted (5-(3-Ethoxy-3-oxopropynyl)-4-(ethoxycarbonyl)-1,2,3-triazolyl-glycosides as Original Nucleoside Analogues to Circumvent Resistance in Myeloid Malignancies.
Journal: Journal of medicinal chemistry
Published: January 18, 2017
Differentiation inducing factor 3 mediates its anti-leukemic effect through ROS-dependent DRP1-mediated mitochondrial fission and induction of caspase-independent cell death.
Journal: Oncotarget
Published: September 29, 2015
BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice.
Journal: The Journal of experimental medicine
Published: June 12, 2015
Pharmacokinetic similarity of biologics: analysis using nonlinear mixed-effects modeling.
Journal: Clinical pharmacology and therapeutics
Published: December 30, 2011
Model-based analyses of bioequivalence crossover trials using the stochastic approximation expectation maximisation algorithm.
Journal: Statistics in medicine
Published: April 29, 2010
Bioequivalence tests based on individual estimates using non-compartmental or model-based analyses: evaluation of estimates of sample means and type I error for different designs.
Journal: Pharmaceutical research
Published: June 08, 2009
Showing 1-11 of 11
Last Updated: 09/26/2026